Anti-psychotic prescriptions for dementia 'need to be reviewed'

Posted on 10 June 2011

A review of how anti-psychotic drugs are incorporated into dementia patients' long term care plans has been demanded by 50 groups, including the Department for Health.

Experts are warning that the drugs can actually worsen symptoms and also increase health risks for the 180,0000 people in the UK who are prescribed medication to treat dementia.

The Dementia Action Alliance coalition wants all prescriptions for anti-psychotics to be reviewed before April 2012.

Care services minister Paul Burstow explained: "It is unacceptable that 1,800 people with dementia die prematurely every year as a result of anti-psychotic medication."

Some of the side effects include mobility problems, sedation and sometimes death, especially when used over a period of more than 12 weeks.

Many critics claim that the majority of anti-psychotics have been incorrectly prescribed, which could be creating further problems for those people paying for care, rather than treating them.


News search form